2-(2-benzyloxycarbonylamino-acetylamino)-benzoic acid methyl ester | 133010-41-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-benzyloxycarbonylamino-acetylamino)-benzoic acid methyl ester
• 英文别名: 2-(2-benzyloxycarbonylaminoacetylamino)benzoic acid methylester；methyl 2-[[2-(phenylmethoxycarbonylamino)acetyl]amino]benzoate
• CAS: 133010-41-0
• 化学式: C₁₈H₁₈N₂O₅
• 分子量: 342.351
• InChiKey: KKWIOYODHYBJKU-UHFFFAOYSA-N

物化性质

• 沸点：
  587.0±45.0 °C(Predicted)
• 密度：
  1.284±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  25
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  93.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(2-benzyloxycarbonylamino-acetylamino)-benzoic acid methyl ester 在 lithium hydroxide 、 N,N'-羰基二咪唑 作用下， 以 1,4-二氧六环 为溶剂， 反应 49.0h， 生成 benzyl N-[[4-oxo-3-(3-propan-2-yloxyphenyl)quinazolin-2-yl]methyl]carbamate
  参考文献：
  名称：

  Novel Nonpeptide CCK-B Antagonists:  Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists

  摘要：

  We have designed a novel series of CCK-B receptor antagonists by combining key pharmacophores, an arylurea moiety of 1 and a quinazolinone ring of 3, from two known series. Our earlier studies showed that compounds with methylene linkers in our "target" produced moderate binding affinity and selectivity for CCK-B receptors, whereas its higher and lower homologues resulted in loss of affinity. Introduction of -NH- as a linker dramatically enhanced binding affinity and selectivity for CCK-B receptors, thus providing several compounds with single-digit nanomolar binding affinity and excellent selectivity. Analogous to the earlier studies of the series of quinazolinone derivatives 3, we also found 3-isopropoxyphenyl as a preferred substitution on the N-3 quinazolinone. Electron-withdrawing substitutions on the urea terminal phenyl ring enhanced the CCK-B potency. Representative compounds of this series were tested in the functional assay and showed pure antagonist profiles. Compounds 51 and 61 were orally active in the elevated rat X-maze test. These compounds were also evaluated for their pharmacokinetic profile. The absolute oral bioavailability of compound 61 was 22% in rats.

  DOI：

  10.1021/jm970373j
• 作为产物：
  描述：

  N-苄氧羰基甘氨酸 、 邻氨基苯甲酸甲酯 在 N,N'-羰基二咪唑 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以11%的产率得到2-(2-benzyloxycarbonylamino-acetylamino)-benzoic acid methyl ester
  参考文献：
  名称：

  Mediators of hedgehog signaling pathways, compositions and uses related thereto

  摘要：

  本发明提供了一种抑制由于刺猬增强功能而导致的异常生长状态的方法和试剂，通过将细胞与刺猬拮抗剂（例如小分子）接触，以足够的量来抑制异常生长状态，例如激活正常的ptc途径或拮抗刺猬活性。

  公开号：

  US09173869B2

文献信息

• Mediators of hedgehog signaling pathways, compositions and uses related thereto
  申请人：Guicherit Oivin M.

  公开号：US09173869B2

  公开（公告）日：2015-11-03

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function by contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize hedgehog activity.

  本发明提供了一种抑制由于刺猬增强功能而导致的异常生长状态的方法和试剂，通过将细胞与刺猬拮抗剂（例如小分子）接触，以足够的量来抑制异常生长状态，例如激活正常的ptc途径或拮抗刺猬活性。
• MEDIATORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO
  申请人：Guicherit Oivin M.

  公开号：US20110077256A1

  公开（公告）日：2011-03-31

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function by contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize hedgehog activity.

  本发明提供了一种通过使用hedgehog拮抗剂（例如小分子）与细胞接触，以足够的量抑制因hedgehog增强功能而导致的异常生长状态的方法和试剂。这种拮抗剂足以激活正常的ptc通路或拮抗hedgehog活性。
• Mediators of hedgehog signalling pathways, compositions and uses related thereto
  申请人：Curis, Inc.

  公开号：EP1516876A1

  公开（公告）日：2005-03-23

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function by contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize hedgehog activity.

  本发明提供了抑制刺猬功能获得所导致的异常生长状态的方法和试剂，其方法是将细胞与刺猬拮抗剂（如小分子）接触，使其达到异常生长状态所需的足够量，如激动正常的 ptc 通路或拮抗刺猬的活性。
• Design and synthesis of novel nonpeptide CCK-B receptor antagonists
  作者：J.K. Padia、H. Chilvers、P. Daum、R. Pinnock、N. Suman-Chauhan、L. webdale、B.K. Trivedi

  DOI：10.1016/s0960-894x(97)00108-x

  日期：1997.1

  A novel hybrid series of nonpeptide CCK-B receptor antagonists has been designed from two known series derived from asperlicin. An efficient synthesis of 2-aminoquinazolinone, an intermediate for the synthesis of a targeted analog, has been developed. (C) 1997 Elsevier Science Ltd.
• US6545005B1
  申请人：——

  公开号：US6545005B1

  公开（公告）日：2003-04-08